Genmab A (GMAB) Revenue Growth (1y) (2019 - 2026)
Genmab A (GMAB) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
37.90% |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Genmab A |
48.34 Bn |
46.82 Bn |
831.00 Mn |
25.31% |
| Date | Value |
|---|
| Mar 31, 2026 |
25.31% |
| Sep 30, 2025 |
25.25% |
| Jun 30, 2025 |
18.74% |
| Mar 31, 2025 |
18.57% |
| Sep 30, 2020 |
165,793,999.88% |
| Dec 31, 2019 |
-100.00% |
